Related Experiment Videos
Chagas' disease: carcinogenic activity of the antitrypanosomal nitroarenes in mice
A R Teixeira1, M A Calixto, M L Teixeira
1Laboratory for Multidisciplinary Research in Chagas' Disease, Faculty of Health Sciences, University of Brasilia, Brazil.
Abstract:
The carcinogenic activity of antitrypanosomal 2-nitroimidazole, 5-nitroimidazole and 5-nitrofuran derivatives was assessed in female Swiss mice of the same age group. A statistically significantly higher incidence of growths was seen in mice into which 2-nitro had been injected than in mice receiving 5-nitro derivatives intraperitoneally. A histologic type of lymphoblastic lymphoma that invades lymph nodes, spleen, liver, lungs and lymphatic tissue elsewhere was frequently found in nitroarene-treated mice. Further, it is shown that the potency of the drug, rather than the duration of its administration, was usually associated with the growth of lymphomas. The 2-nitro derivative which induced the highest incidence of lymphomas significantly decreased the survival of treated mice; this probably occurred because it undergoes enzymatic reduction of the nitro group more efficiently than the 5-nitro compounds used. The differences of incidence of lymphomas in mice receiving any of these nitroarenes and in control mice that received daily injections of 0.15 M saline were statistically significant (alpha = 0.05). The indiscriminate use of these nitroarenes to treat Trypanosoma cruzi infections in man could therefore induce a significant number of lymphomas.
Insights
Certain nitroimidazole and nitrofuran drugs used to treat parasitic infections may cause cancer. Specifically, 2-nitroimidazole derivatives were linked to a higher incidence of lymphomas in mice, potentially posing risks for human patients.
Area of Science:
- Pharmacology
- Toxicology
- Oncology
Background:
- Antitrypanosomal nitroimidazoles and nitrofurans are used to treat parasitic infections.
- The carcinogenic potential of these compounds, particularly 2-nitroimidazole derivatives, requires thorough investigation.
Purpose of the Study:
- To assess the carcinogenic activity of antitrypanosomal 2-nitroimidazole, 5-nitroimidazole, and 5-nitrofuran derivatives.
- To investigate the relationship between drug potency, administration duration, and lymphoma development.
Main Methods:
- Female Swiss mice were administered 2-nitroimidazole, 5-nitroimidazole, and 5-nitrofuran derivatives intraperitoneally.
- Incidence of growths, histologic type, and survival rates were analyzed.
- Statistical significance was determined using alpha = 0.05.
Main Results:
- A significantly higher incidence of lymphoblastic lymphoma was observed in mice treated with 2-nitroimidazole derivatives compared to 5-nitro derivatives.
- Lymphoma development was more strongly associated with drug potency than administration duration.
- The 2-nitro derivative that induced the highest lymphoma incidence significantly decreased mouse survival, likely due to efficient enzymatic nitro group reduction.
Conclusions:
- The indiscriminate use of these nitroarene derivatives for treating Trypanosoma cruzi infections in humans may lead to a significant number of lymphomas.
- Further research is warranted to evaluate the long-term safety and carcinogenic risks of these antitrypanosomal agents.